| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CELZ | Common Stock | Purchase | $4,000 | +10,000 | +11% | $0.4000 | 97,087 | 21 Nov 2022 | Direct | |
| transaction | CELZ | Common Stock | Purchase | $1,965 | +5,000 | +5.2% | $0.3930 | 102,087 | 21 Nov 2022 | Direct | |
| transaction | CELZ | Common Stock | Purchase | $3,822 | +9,800 | +9.6% | $0.3900 | 111,887 | 22 Nov 2022 | Direct | |
| transaction | CELZ | Common Stock | Purchase | $75.42 | +200 | +0.18% | $0.3771 | 112,087 | 22 Nov 2022 | Direct | |
| holding | CELZ | Common Stock | 226,948 | 21 Nov 2022 | Entity | F1 |
| Id | Content |
|---|---|
| F1 | Owned by Creative Medical Health, Inc., of which Mr. Warbington serves as President and Chief Executive Officer. |